Aptorum Group (APM) Competitors $2.37 -0.04 (-1.66%) As of 11:24 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock APM vs. PHGE, ZIVO, PDSB, RNXT, ANVS, SNTI, VRCA, XLO, LVTX, and MDCXShould you be buying Aptorum Group stock or one of its competitors? The main competitors of Aptorum Group include BiomX (PHGE), ZIVO Bioscience (ZIVO), PDS Biotechnology (PDSB), RenovoRx (RNXT), Annovis Bio (ANVS), Senti Biosciences (SNTI), Verrica Pharmaceuticals (VRCA), Xilio Therapeutics (XLO), LAVA Therapeutics (LVTX), and Medicus Pharma (MDCX). These companies are all part of the "pharmaceutical products" industry. Aptorum Group vs. Its Competitors BiomX ZIVO Bioscience PDS Biotechnology RenovoRx Annovis Bio Senti Biosciences Verrica Pharmaceuticals Xilio Therapeutics LAVA Therapeutics Medicus Pharma Aptorum Group (NASDAQ:APM) and BiomX (NYSEMKT:PHGE) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Which has preferable earnings & valuation, APM or PHGE? Aptorum Group has higher revenue and earnings than BiomX. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptorum Group$430K29.49-$4.27MN/AN/ABiomXN/AN/A-$28.32M-$1.36-0.44 Is APM or PHGE more profitable? Aptorum Group's return on equity of 0.00% beat BiomX's return on equity.Company Net Margins Return on Equity Return on Assets Aptorum GroupN/A N/A N/A BiomX N/A -127.82%-56.50% Does the media favor APM or PHGE? In the previous week, Aptorum Group had 5 more articles in the media than BiomX. MarketBeat recorded 5 mentions for Aptorum Group and 0 mentions for BiomX. BiomX's average media sentiment score of 0.00 beat Aptorum Group's score of -0.54 indicating that BiomX is being referred to more favorably in the news media. Company Overall Sentiment Aptorum Group Negative BiomX Neutral Do insiders & institutionals believe in APM or PHGE? 3.8% of Aptorum Group shares are owned by institutional investors. Comparatively, 40.6% of BiomX shares are owned by institutional investors. 64.0% of Aptorum Group shares are owned by company insiders. Comparatively, 3.0% of BiomX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, APM or PHGE? Aptorum Group has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500. Comparatively, BiomX has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Do analysts prefer APM or PHGE? BiomX has a consensus target price of $21.00, indicating a potential upside of 3,441.32%. Given BiomX's stronger consensus rating and higher possible upside, analysts plainly believe BiomX is more favorable than Aptorum Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptorum Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00BiomX 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAptorum Group and BiomX tied by winning 6 of the 12 factors compared between the two stocks. Get Aptorum Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APM vs. The Competition Export to ExcelMetricAptorum GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.68M$2.65B$9.08B$10.58BDividend YieldN/A56.71%5.69%4.71%P/E RatioN/A23.4386.1627.45Price / Sales29.49583.66539.92202.26Price / CashN/A173.2337.9261.55Price / Book1.085.5913.056.77Net Income-$4.27M$32.78M$3.30B$275.88M7 Day Performance7.24%5.84%4.55%2.63%1 Month Performance31.67%13.22%9.73%9.10%1 Year Performance36.99%2.13%85.10%35.69% Aptorum Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APMAptorum Group0.502 of 5 stars$2.37-1.7%N/A+40.1%$12.68M$430K0.0030News CoverageAnalyst ForecastShort Interest ↓PHGEBiomX1.7608 of 5 stars$0.57-23.3%$21.00+3,603.7%-37.8%$13.76MN/A-0.73120ZIVOZIVO Bioscience0.1387 of 5 stars$11.75-2.3%N/A-38.5%$44.85M$15.85K-2.4110Gap UpPDSBPDS Biotechnology1.6696 of 5 stars$0.95-1.3%$10.00+952.6%-71.9%$44.68MN/A-1.0320Analyst ForecastRNXTRenovoRx1.7502 of 5 stars$1.21-10.1%$7.50+522.4%+21.1%$44.16M$40K-3.176Analyst ForecastHigh Trading VolumeANVSAnnovis Bio2.4381 of 5 stars$2.27+0.2%$17.33+665.3%-72.7%$44.15MN/A-1.113News CoverageAnalyst ForecastGap UpSNTISenti Biosciences1.9688 of 5 stars$1.67flat$8.50+409.0%-25.2%$43.69M$2.56M-0.194Analyst ForecastVRCAVerrica Pharmaceuticals3.7933 of 5 stars$4.62-1.5%$60.00+1,198.7%-65.5%$43.64M$14.70M-0.5640News CoverageAnalyst ForecastGap DownXLOXilio Therapeutics1.6408 of 5 stars$0.83+0.2%$3.00+263.2%+11.8%$42.81M$6.34M-1.0970Analyst ForecastGap UpLVTXLAVA Therapeutics1.5179 of 5 stars$1.61-0.3%$2.69+67.3%-3.7%$42.23M$11.98M-1.5360Analyst ForecastMDCXMedicus Pharma2.6529 of 5 stars$2.37-6.0%$23.50+891.6%N/A$42.22MN/A-1.77N/AAnalyst Forecast Related Companies and Tools Related Companies PHGE Competitors ZIVO Competitors PDSB Competitors RNXT Competitors ANVS Competitors SNTI Competitors VRCA Competitors XLO Competitors LVTX Competitors MDCX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APM) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptorum Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptorum Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
